@article{a0aabffdd4604f6b96729c75be562455,
title = "Re: Cost-Effectiveness of Pembrolizumab in Second-Line Advanced Bladder Cancer",
author = "M. Sarfaty and Hall, {P. S.} and Chan, {K. K.W.} and K. Virik and M. Leshno and N. Gordon and A. Moore and V. Neiman and E. Rosenbaum and Goldstein, {D. A.}",
note = "Funding Information: We would like to thank the patients and the staff of the dialysis and transplant units for contributing the data via their national and regional renal registries. Furthermore, we gratefully acknowledge the following registries and persons for their contribution of the data: Austrian Dialysis and Transplant Registry [OEDTR] (R. Kramar); Dutch speaking Belgian Society of Nephrology [NBVN] (M. Couttenye and F. Schroven); French speaking Belgian Society of Nephrology [GNFB] (J. M. des Grottes); Danish Nephrology Registry [DNS]; Finnish Registry for Kidney Diseases (A. Pylsy and P. H. Groop); France: The Epidemiology and Information Network in Nephrology [REIN] (M. Lassalle and C. Couchoud); Hellenic Renal Registry (N. Afentakis); Icelandic End-Stage Renal Disease Registry; Norwegian Renal Registry (T. Leivestad, A. V. Reis{\ae}ter, and A. {\AA}sberg); Swedish Renal Registry [SRR] (K. G. Pr{\"u}tz, M. Stendahl, S. Sch{\"o}n, T. Lundgren, and M. Segelmark); Dutch Renal Registry [RENINE] (L. Heuveling, S. Vogelaar, and M. Hemmelder); UK Renal Registry (all the staff of the UK Renal Registry and of the renal units submitting data); Scottish Renal Registry [SRR] (all of the Scottish renal units); and the regional registries of Andalusia [SICATA] (P. Castro de la Nuez; on behalf of all users of SICATA), Aragon (F. Arribas Monz{\'o}n, J. M. Abad Diez, and J. I. Sanchez Miret), Asturias (R. Alonso de la Torre, J. R. Quir{\'o}s, and RERCA Working Group), Basque country [UNIPAR] ({\'A}. Magaz, J. Aranzabal, M. Rodrigo, and I. Moina), Cantabria (J. C. Ruiz San Mill{\'a}n, O. Garcia Ruiz, and C. Pi{\~n}era Haces), Castile and Le{\'o}n (M. A. Palencia Garc{\'i}a), Catalonia [RMRC] (E. Arcos, J. Comas, and J. Tort), and Valencian region [REMRENAL] (M. Ferrer Alamar, N. Fuster Camarena, and J. P{\'e}rez Penad{\'e}s); and the other ERA-EDTA registry committee members not mentioned above for their advice in the analyses and the drafting of this paper: J. Harambat, L. Mercadal, M. Nordio, S. S. S{\o}rensen, and E. Vidal; and M. Pippias in the AMC Registry office for data collection and management. The ERA-EDTA Registry is funded by the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA). Finally, we would like to thank B. Foster and X. Zhang for explaining their analyses. ",
year = "2019",
month = dec,
day = "1",
doi = "10.1097/01.JU.0000585768.72427.cb",
language = "אנגלית",
volume = "202",
pages = "1095",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Wolters Kluwer Health",
number = "6",
}
